FDA approves Qiagen’s TB blood test: 3 things to know

The Food and Drug Administration on Thursday approved Qiagen’s fourth generation tuberculosis blood test.

Advertisement

Here are three things to know.

  1. The Quantiferon-TB Gold Plus test is designed to detect latent tuberculosis in patients.
  1. The blood test offers a broad look into an individual’s immune response to tuberculosis, according to a news release.
  1. Qiagen plans to launch the new test later this year.

More articles on supply chain:

7 drugmakers in the headlines
4 ways hospitals can lower inpatient drug costs
6 must-reads for supply chain leaders this week

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.